Individual generic drug information

plerixafor

Reference monograph

Part of registered formulation

PLERIXAFOR

Reference record: plerixafor
Source: Mosby’s 2024 Nursing Drug Reference
Printed source pages: 1062
Age groups indexed: Not recorded

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for plerixafor only.

Names and pronunciation

(pler-ix′a-fore) Mozobil

Source page 1062

Functional class

Func. class.: Biologic modifier

Source page 1062

Uses

USES: Mobilization of hematopoietic stem cells for collection and transplantation (in combination with filgrastim) in non- Hodgkin lymphoma and multiple myeloma

Source page 1062

Safety

Extracted information for plerixafor only.

Contraindications

CONTRAINDICATIONS Hypersensitivity

Source page 1062

Dose and formulations

Extracted information for plerixafor only.

Dosage and routes

DOSAGE AND ROUTES Hematopoietic stem cell mobiliza- tion (in non-Hodgkin lymphoma and multiple myeloma) Adult: SUBCUT Give 11 hr before apheresis: ≤83 kg: 20-mg fixed dose or 0.24 mg/kg daily for up to 4 con- secutive days; >83 kg: 0.24 mg/kg daily for up to 4 consecutive days; max 40 mg/day

Source page 1062

Available forms

Available forms: Injection 24 mg/1.2 mL single-use vial

Source page 1062

Dose text by age group

Filter the extracted dose blocks for this individual drug.

No dose block was identified for this age filter. This does not establish whether the drug is suitable for that age group.

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.

Individual generic drug information

plerixafor

Reference monograph

Part of registered formulation

PLERIXAFOR

Reference record: plerixafor
Source: Mosby’s 2024 Nursing Drug Reference
Printed source pages: 1062
Age groups indexed: Not recorded

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for plerixafor only.

Names and pronunciation

(pler-ix′a-fore) Mozobil

Source page 1062

Functional class

Func. class.: Biologic modifier

Source page 1062

Uses

USES: Mobilization of hematopoietic stem cells for collection and transplantation (in combination with filgrastim) in non- Hodgkin lymphoma and multiple myeloma

Source page 1062

Safety

Extracted information for plerixafor only.

Contraindications

CONTRAINDICATIONS Hypersensitivity

Source page 1062

Dose and formulations

Extracted information for plerixafor only.

Dosage and routes

Source page 1062

Available forms

Available forms: Injection 24 mg/1.2 mL single-use vial

Source page 1062

Dose text by age group

Filter the extracted dose blocks for this individual drug.

No dose block was identified for this age filter. This does not establish whether the drug is suitable for that age group.

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.